Table 1. Investigations at the tertiary care hospital.
ELISA: enzyme-linked immunosorbent assay; HBsAg: hepatitis B surface antigen; HCV: hepatitis C virus; HIV: human immunodeficiency virus; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; PCR: polymerase chain reaction; RBS: random blood sugar; TSH: thyroid-stimulating hormone
| Investigation | Result | Reference range |
| WBC (×103/µL) | 13.0 | 4–11 |
| RBC (×106/µL) | 4.66 | 4–6 |
| Hb (g/dL) | 11.8 | 11.5–17.5 |
| HCT (%) | 36.5 | 36–54 |
| MCV (fL) | 78.3 | 76–96 |
| MCH (pg) | 25.3 | 27–33 |
| MCHC (g/dL) | 32.3 | 33–35 |
| Platelet count (×103/µL) | 553 | 150–450 |
| Neutrophils (%) | 65 | 7.2–11 |
| Lymphocytes (%) | 30 | 20–45 |
| Monocytes (%) | 02 | 2–10 |
| Eosinophils (%) | 02 | 0–6 |
| CRP (mg/dL) | 40.5 | <0.5 |
| Total bilirubin (mg/dL) | 0.8 | 0.1–1.2 |
| ALP (U/L) | 244 | <275 |
| ALT (U/L) | 132 | 10–41 |
| CPK (U/L) | 2,225 | 25–200 |
| Urea (mg/dL) | 29 | 10–40 |
| Creatinine (mg/dL) | 1.1 | 0.2–1.2 |
| HBsAg (ELISA) | Non-reactive | Non-reactive |
| Anti-HCV (ELISA) | Non-reactive | Non-reactive |
| Anti-HIV (ELISA) | Non-reactive | Non-reactive |
| SARS-CoV-2 PCR | Negative | Negative |
| RBS (mg/dL) | 110 | 60–150 |
| TSH (mIU/L) | 1.3 | 0.5–5.0 |
| Na (mEq/L) | 130 | 135–145 |
| K (mEq/L) | 5.2 | 3.5–5.5 |
| Cl (mEq/L) | 97.4 | 95–110 |
| Urinalysis | Normal | |
| Chest X-ray | Normal | |
| Ultrasound of the abdomen and pelvis | Fatty liver and atrophic left kidney | |